Red Light-Initiated Cross-Linking of NIR Probes to Cytoplasmic RNA: An Innovative Strategy for Prolonged Imaging and Unexpected Tumor Suppression
Shuyue Ye,Chaoxiang Cui,Xiaju Cheng,Meng Zhao,Qiulian Mao,Yuqi Zhang,Anna Wang,Jing Fang,Yan Zhao,Haibin Shi
DOI: https://doi.org/10.1021/jacs.0c10755
IF: 15
2020-12-11
Journal of the American Chemical Society
Abstract:Improving the enrichment of drugs or theranostic agents within tumors is very vital to achieve effective cancer diagnosis and therapy while greatly reducing the dosage and damage to normal tissues. Herein, as a proof of concept, we for the first time report a red light-initiated probe-RNA cross-linking (RLIPRC) strategy that can not only robustly promote the accumulation and retention of the probe in the tumor for prolonged imaging but also significantly inhibits the tumor growth. A near-infrared (NIR) fluorescent probe <i>f</i>-CR consisting of a NIR dye (Cyanine 7) as a signal reporter, a cyclic-(arginine-glycine-aspartic acid) (cRGD) peptide for tumor targeting, and a singlet oxygen (<sup>1</sup>O<sub>2</sub>)-sensitive furan moiety for RNA cross-linking was rationally designed and synthesized. This probe possessed both passive and active tumor targeting abilities and emitted intense NIR/photoacoustic (PA) signals, allowing for specific and sensitive dual-modality imaging of tumors in vivo. Notably, probe <i>f</i>-CR could be specifically and covalently cross-linked to cytoplasmic RNAs via the cycloaddition reaction between furan and adenine, cytosine, or guanine under the oxidation of <sup>1</sup>O<sub>2</sub> generated in situ by irradiation of methylene blue (MB) with 660 nm laser light, which effectively blocks the exocytosis of the probes resulting in enhanced tumor accumulation and retention. More excitingly, for the first time, we revealed that the covalent cross-linking of probe <i>f</i>-CR to cytoplasmic RNAs could induce severe apoptosis of cancer cells leading to remarkable tumor suppression. This study thus represents the first red light-initiated RNA cross-linking system with high potential to improve the diagnostic and therapeutic outcomes of tumors in vivo.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c10755?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c10755</a>.Synthetic methods, synthetic routes, characterizations of all compounds; UV absorption of CR and TEM of control group; Cy7 fluorescence intensity standard curve; photoacoustic signal intensity of <i>f</i>-CR solutions at different concentrations; hydrated particle size distribution of <i>f</i>-CR; mass spectrum data after <i>f</i>-CR-RNA cross-linking; cross-linking efficiency under the different MB concentrations; difference of <i>f</i>-CR uptake in 3T3 and 4T1 cells; cells uptake changes of probes at different time points; cytotoxicity of MB; the capability of MB to produce ROS; electrophoresis to investigate RNA in the nucleus; protein electrophoresis to investigate the total proteins in the whole cell; fluorescence intensity change of tumors in vivo at different time points; apoptotic evaluation; weight measurement of the isolated tumor after the different combination treatments, including Schemes S1–S3, Figures S1–S28, Table S1, and RNA information (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c10755/suppl_file/ja0c10755_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
chemistry, multidisciplinary